Protease-activated receptor 2 enhances renal cell carcinoma cell invasion and migration via PI3K/AKT signaling pathway

Exp Mol Pathol. 2015 Jun;98(3):382-9. doi: 10.1016/j.yexmp.2015.03.018. Epub 2015 Mar 13.

Abstract

Protease-activated receptor 2 (PAR-2) has been implicated in the regulation of several cellular functions in the progression of cancer. It is reported that PAR-2 expression is significantly increased in human renal cell carcinoma (RCC) tissue compared with the adjacent non-neoplastic kidney tissue. However, the function of PAR-2 in regulating cell invasion and migration of RCC remains elusive. In this study, we found that PAR-2 was overexpressed in RCC cells. Activation of PAR-2 with PAR-2AP (PAR-2 agonist) enhanced the invasion and migration of RCC cells, and increased the expressions of MMP-13 and urokinase plasminogen activator (uPA). However, knockdown of PAR-2 by siRNA could intervene in all regulating effects of PAR-2AP. Furthermore, activation of PAR-2 induced the activation of PI3K and AKT, and PI3K/AKT inhibitor LY294002 attenuated the invasion and migration of RCC cells stimulated by PAR-2 activation. Altogether, our study demonstrates that PAR-2 stimulates the activation of PI3K/AKT pathway, subsequently increasing the expressions of MMP-13 and uPA, and thereby promotes the invasion and migration of RCC cells.

Keywords: Invasion; MMP-13; PAR-2; PI3K/AKT pathway; Renal cell carcinoma; uPA.

MeSH terms

  • Carcinoma, Renal Cell / metabolism*
  • Carcinoma, Renal Cell / pathology
  • Cell Line
  • Cell Line, Tumor
  • Cell Movement*
  • Humans
  • Kidney Neoplasms / metabolism*
  • Kidney Neoplasms / pathology
  • Matrix Metalloproteinase 3 / genetics
  • Matrix Metalloproteinase 3 / metabolism
  • Neoplasm Invasiveness
  • Phosphatidylinositol 3-Kinases / metabolism
  • Plasminogen Activators / genetics
  • Plasminogen Activators / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Receptor, PAR-2 / genetics*
  • Receptor, PAR-2 / metabolism
  • Signal Transduction*

Substances

  • Receptor, PAR-2
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Plasminogen Activators
  • MMP3 protein, human
  • Matrix Metalloproteinase 3